General
Preferred name
ORBIFLOXACIN
Synonyms
CP-104354 ()
Orbifloxacine ()
Orbifloxacino ()
Orbax ()
NSC-758614 ()
P&D ID
PD000884
CAS
113617-63-3
Tags
available
drug
Approved by
FDA
Drug Status
vet_approved
approved
investigational
experimental
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Orbifloxacin is a fluoroquinolone antibacterial compound . It was developed for use in veterinary medicine. (GtoPdb)
PRICE 29
DESCRIPTION Orbifloxacin is a synthetic broad-spectrum fluoroquinolone antibiotic which is approved for use in dogs.
DESCRIPTION Orbifloxacin is a third generation of fluoroquinolone that exhibits increased antibacterial activity against the Enterobacteriaceae, gram-negative and gram-positive bacteria, anaerobes, and mycobacteria. (BOC Sciences Bioactive Compounds)
DESCRIPTION Orbifloxacin (CP-104354) is a broad-spectrum fluoroquinolone antibiotic. (TargetMol Bioactive Compound Library)
Cell lines
0
Organisms
1
Compound Sets
13
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
32
Properties
(calculated by RDKit )
Molecular Weight
395.15
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
4
Aromatic Ring Count
2
cLogP
2.64
TPSA
74.57
Fraction CSP3
0.47
Chiral centers
2.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Antibacterial
antibiotic
Bacterial
Indication
urinary tract infections
MOA
bacterial DNA gyrase inhibitor
Pathway
Microbiology/virology
Anti-infection
Source data